EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression

Melinda Pohle, Edward Curry iD, Ryan Holden, Suzanne Gibson, Adam Brown

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Melinda Pohle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, University of Sheffield, Sheffield, S1 3JD, United Kingdom. Hauptthemen laut MEDLINE: G-Quadruplexes, Recombinant Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca, Engineering and Physical Sciences Research Council, University of Sheffield.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Control of mammalian recombinant protein expression underpins the in vitro manufacture and in vivo performance of all biopharmaceutical products. However, routine optimization of protein expression levels in these applications is hampered by a paucity of genetic elements that function predictably across varying molecular formats and host cell contexts. Herein, we describe synthetic genetic components that are specifically built to simplify bioindustrial expression cassette design processes. Synthetic G-quadruplex elements with varying sequence feature compositions were systematically designed to exhibit a wide range of regulatory activities and inserted into identified optimal positions within a standardized, bioindustry compatible core promoter-5′UTR control unit. The resulting library tuned protein production rates over two orders of magnitude, where DNA and RNA G-quadruplexes could be deployed individually or in combination to achieve synergistic two-level regulatory control. We demonstrate these components can predictably and precisely tailor protein expression levels in (i) varying gene therapy and biomanufacturing cell hosts and (ii) both plasmid DNA and synthetic messenger RNA contexts. As an exemplar use case, a vector design platform was created to facilitate rapid optimization of polypeptide expression ratios for difficult-to-express multichain products. Permitting simple, predictable titration of recombinant protein expression, this technology should prove useful for gene therapy and biopharmaceutical manufacturing applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-QuadruplexesRecombinant ProteinsHumansPromoter Regions, GeneticAnimals5' Untranslated RegionsPlasmidsDNAGenetic VectorsRNA, MessengerGene Expression RegulationHEK293 Cells

Substanzen

Recombinant Proteins5' Untranslated RegionsDNARNA, Messenger

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering, University of Sheffield, Sheffield, S1 3JD, United Kingdom.
  • BioPharmaceutical Development, R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.

ORCID-Profile: Edward Curry

Förderung

  • AstraZeneca
  • Engineering and Physical Sciences Research Council
  • University of Sheffield

Zitieren

APA

Pohle, M., Curry, E., Holden, R., Gibson, S., & Brown, A. (2025). Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf732

Vancouver

Pohle M, Curry E, Holden R, Gibson S, Brown A. Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf732

BibTeX
@article{Pohle2025,
  author = {Pohle, Melinda and Curry, Edward and Holden, Ryan and Gibson, Suzanne and Brown, Adam},
  title = {Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf732}
}
Kostenlos starten →